The
slide to be stained for AMACR comprised:
1. Prostate hyperplasia, 2-3. Prostate adenocarcinoma.
All specimens were fixed in 10 % NBF.Criteria for assessing an AMACR staining as optimal included:
- A moderate to strong cytoplasmic staining of the two prostate adenocarcinomas
- A negative or week focal cytoplasmic
staining of the hyperplastic prostate glands
- A negative or week cytoplasmic staining of the
stromal cells.
65 laboratories submitted stains. At the assessment 39
achieved optimal marks (60 %), 19 good (29 %), 6 borderline (9 %)
and 1 (2 %) poor marks.
The following Abs were used:
mAb clone 13H4 (Dako, n=47; Biologo, n=4; Zeta Corporation, n=1)
mAb clone P504-S (Immunologic, n=1)
pAb CP200 & PP200 (BioCare, n=9; PP200: cocktail of P504S + p63)
pAb ab12498 (Abcam, n=1)
pAb RB9407 (NeoMarkers, n=1)
pAb RP134 (Diagnostic Biosystems, n=1)
Optimal staining for AMACR in this assessment was obtained with the
rmAb clone 13H4 (33 out of 52 (63%)), and the pAbs CP200/PP200, (5 out of 9)
and ab12498 (1 out of 1).
All optimal protocols were based on Heat Induced Epitope Retrieval
(HIER).
Using the clone 13H4, HIER in Tris-EDTA/EGTA pH 9 (30 out of 41),
EDTA/EGTA pH8 (1 out of 3) and CC1/Ventana (2 out of 6) gave an
optimal staining. The clone 13H4 was used in the range of 1:40 –
1:300 depending on the total sensitivity of the protocol employed.
Using the pAb CP200/PP200 optimal staining was obtained with HIER in
CC1/Ventana (2 out of 2), Tris-EDTA/EGTA pH9 (2 out of 3) and Borg/BioCare
(1 out of 2). The pAb CP200/PP200 was used in the range of 1:100 –
1:200 depending on the total sensitivity of the protocol employed, or
as a ready-to-use Ab.
The pAb ab12498 gave an optimal staining using a dilution of 1:100 (overnight
4ºC) and HIER in Citrate pH 6.
The most frequent causes of insufficient
stains were:
- Too low concentration of the primary antibody
- Too high concentration of the primary antibody
In the assessment the prevalent feature of an insufficient staining
was a too weak or false negative staining of the epithelial cells in
the prostate carcinomas probably due to a too low concentration of the
primary Ab. In a few cases the staining was too strong, which
gave a distinct cytoplasmic granular reaction in the normal
epithelial cells in the prostate hyperplasia imitating the
reactivity expected in carcinoma. In case of a very strong
reaction in the epithelial cells of the prostate carcinoma, the
smooth muscle cells typically showed a moderate positive staining.
They main issue in the immunohistochemical demonstration of AMACR
seems to be a correct calibration of the primary Ab resulting in a
negative or only weak and focal reaction in normal prostate
epithelial cells and a strong granular reaction of the majority of
the neoplastic cells in a prostate adenocarcinoma.
Conclusion
- The mAb clone 13H4, the pAb CP200 (used alone or combined with p63
as in
RP200; both from Biocare) and the pAb ab12498 seem to be appropriate markers for AMACR
- HIER is recommended for optimal performance of all the Abs.
As control for AMACR a multitissue block containing both normal prostate,
prostate in situ neoplasia (PIN) and prostate adenocarcinoma is
appropriate. |